Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05318703
Other study ID # AG059546-02S1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 20, 2021
Est. completion date October 30, 2022

Study information

Verified date March 2023
Source Oregon Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project is designed to develop and evaluate an Internet-based exercise intervention (tai ji quan Moving to Improve Brain Health) using real-time videoconferencing for older adults with mild cognitive impairment (MCI).


Description:

The project has three major goals: (a) transforming an in-person tai ji quan brain health intervention protocol into an online (virtual) class protocol and evaluating its feasibility of implementation in older adults with MCI, (b) developing and evaluating online assessment and data ascertainment procedures that encompass cognitive and physical performance measures, and (c) conducting a randomized controlled trial comparing the effectiveness of this new online intervention protocol with a conventional stretching exercise group in older adults with MCI.


Recruitment information / eligibility

Status Completed
Enrollment 69
Est. completion date October 30, 2022
Est. primary completion date August 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years to 95 Years
Eligibility Inclusion criteria: - Self-report a change or decline in memory (corroborated by an informant) - Record a score of =0.5 on the Clinical Dementia Rating (CDR) scale (with information derived from both the participant and an informant) - Show no major impairment in cognitive function as indexed by a score of =24 on the Mini Mental State Evaluation (MMSE). Exclusion criteria: - Have participated in a rigorous and structured physical activity or exercise program (including Tai Ji Quan) in the past 6 months, - Show major signs of depression as indicated by a score of =5 on the Geriatric Depression Scale - Have major medical or physical conditions that preclude exercise, as determined by their healthcare practitioner - Being unable to follow the consent process or sign the study consent form.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
tai ji quan
cognitively enhanced tai ji quan exercise
Stretching
Stretching exercise

Locations

Country Name City State
United States Oregon Research Institute Eugene Oregon

Sponsors (1)

Lead Sponsor Collaborator
Oregon Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary (a) Total number of intervention sessions taught by instructors over the course of study (recorded by a class check sheet) and (b) total number of classes attended by participants over the course of intervention as recorded by class attendance sheet assess the extent to which interventionists successfully implement the prespecified exercise training protocol. 16 weeks
Primary number of dropouts from the intervention and study as assessed by a study recording sheet assess intervention dropout rate and retention rate 16 weeks
Primary Number of participants expressing intervention program satisfaction as assessed by a self-report survey assess the program acceptability among tai ji quan participants 16 weeks
Primary Change in global cognitive function assessed by Montreal Cognitive Assessment assess change from baseline cognitive function at 16 weeks baseline, 16 weeks
Primary Change in attention and working memory as assessed by Digit Span - forward and backward assess change from baseline in attention and working memory at 16 weeks baseline, 16 weeks
Primary Change in dual-task cost as assessed by Timed Up and Go with a cognitive task assess change from baseline in the ability to stand up from a chair, walk, and sit down while performing an arithmetic task at 16 weeks baseline, 16 weeks
Primary Change in executive function as assessed by Trail Making B assess change from baseline executive function at 16 weeks baseline, 16 weeks
Primary Change in executive function as assessed by Category Fluency for Animals assess change from baseline executive function at 16 weeks baseline, 16 weeks
Primary Change in cognitive functioning assessed by Everyday Cognition assess change from baseline cognitive functioning at 16 weeks baseline, 16 weeks
Primary Change in physical performance as measured by Timed Up and Go test assess change from baseline in the ability to stand up from a chair, walk, and sit down at 16 weeks baseline, 16 weeks
Primary change in leg strength as assessed by 30-second chair stand test assess change from baseline in leg strength at 16 weeks baseline, 16 weeks
Primary Change in balance using a 4-stage balance test assess change from baseline in balance at 16 weeks baseline, 16 weeks
Secondary Change in depression as assessed by Geriatric Depression scale assess change from baseline in the level of depression at 16 weeks baseline, 16 weeks
Secondary Change in physical activity as assessed by International Physical Activity Questionnaire assess change from baseline in physical activity at 16 weeks baseline, 16 weeks
Secondary Change in quality of life as assessed by EuroQol (EQ-5D-3L) assess change from baseline in quality of life at 16 weeks baseline, 16 weeks
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A